Skip to main content
Equibles

MORGAN STANLEY

Position in INMB — Inmune Bio, Inc.

CIK 895421 NEW YORK, NY
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,428
-$35,979 QoQ
Shares Held
8,853
-80.2% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 83 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 32% Shared 0% None 68%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. INMB ranks #415 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in INMB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,428 8,853
2026-03-31 $50,407 44,611
2025-12-31 $191,116 122,512
2025-09-30 $156,716 75,710
2025-06-30 $237,322 102,738
2025-03-31 $659,662 84,464
2024-12-31 $724,435 155,126
2024-09-30 $496,653 92,144
2024-06-30 $250,266 28,375
2024-03-31 $322,876 27,479
2023-12-31 $144,161 12,803
2023-09-30 $27,627 4,081
2023-06-30 $45,345 4,994
2023-03-31 $31,116 4,817
2022-12-31 $18,943 2,988
2022-09-30 $799,800 129,000
2022-06-30 $1,841,211 208,282
2022-03-31 $2,530,049 300,481
2021-12-31 $3,860,566 378,487
2021-09-30 $478,332 24,631
2021-06-30 $202,809 11,543
2021-03-31 $36,744 3,093
2020-12-31 $26,983 1,567
2020-09-30 $10,310 1,000